Trial Profile
A open, prospective, multicentral, observational and non-comparative study to evaluate benefits of fix full dose , combination of perindopril A and indapamide for uncontrolled arterial hypertension treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2021
Price :
$35
*
At a glance
- Drugs Perindopril/indapamide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms FORTISSIMO
- 25 Feb 2021 Results of a post-hoc pooled analysis from four clinical observational studies: FORTISSIMO, FORSAGE, ACES and PICASSO published in the Advances in Therapy
- 20 Dec 2015 New trial record